Methods and compositions for the inhibition of modulation of T cell costimulatory pathway by a pathogenic agent

Details for Australian Patent Application No. 2011205019 (hide)

Owner Yissum Research Development Company of the Hebrew University of Jerusalem

Inventors Arad, Gila; Kaempfer, Raymond

Agent Davies Collison Cave

Pub. Number AU-A-2011205019

Parent 2004226566

Filing date 27 July 2011

Wipo publication date 18 August 2011

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

11 August 2011 Complete Application Filed

18 August 2011 Application Open to Public Inspection

  Published as AU-A-2011205019

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011205020-Gaming machine

2011205018-A gaming apparatus with a wheel game